Aviva Biosciences Pockets $11.8M in Series B Round

genomeweb
360dx

Aviva Biosciences Pockets $11.8M in Series B Round

Sep 23, 2002

NEW YORK, Sept. 23 - Startup biochip company Aviva Biosciences today said it has secured $11.8 million in the first closing of a series B round of private-equity financing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug
Precipio Reports 140 Percent Jump in Preliminary Q3 Revenues
Scripps Research Translational Institute, Seqster Partner to Engage Consumers on Heart Disease Risk
BD Obtains CE Mark for Molecular TB, MDR-TB Assay
Team Taps Large Population PheWAS For Clues to Drug Targets, Side Effects
Precision for Medicine Acquires ApoCell

The Scan

In on the Action

NPR reports that with medical data being big business, some companies want to get patients involved.

What's in Store?

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

This Week in PNAS

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Warren Releases Genetic Ancestry Results

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Main menu